Neuronetics (STIM) Enterprise Value Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.56% |
| Dec 31, 2025 | -181.85% |
| Sep 30, 2025 | -12.61% |
| Jun 30, 2025 | 94.65% |
| Mar 31, 2025 | 64.68% |
| Dec 31, 2024 | 104.77% |
| Sep 30, 2024 | 41.77% |
| Jun 30, 2024 | 7.76% |
| Mar 31, 2024 | 14.38% |
| Dec 31, 2023 | 15.72% |
| Sep 30, 2023 | 51.29% |
| Jun 30, 2023 | 35.68% |
| Mar 31, 2023 | 31.63% |
| Dec 31, 2022 | 25.39% |
| Sep 30, 2022 | 25.57% |
| Jun 30, 2022 | 38.02% |
| Mar 31, 2022 | 32.70% |
| Dec 31, 2021 | -89.48% |
| Sep 30, 2021 | -93.99% |
| Jun 30, 2021 | -113.04% |
| Mar 31, 2021 | -90.28% |
| Dec 31, 2020 | 33.61% |
| Sep 30, 2020 | 36.94% |
| Jun 30, 2020 | 38.47% |
| Mar 31, 2020 | 32.73% |
| Dec 31, 2019 | 26.77% |
| Sep 30, 2019 | 22.25% |
| Jun 30, 2019 | -518.01% |
| Dec 31, 2018 | -258.81% |
| Jun 30, 2018 | 44.56% |
| Dec 31, 2017 | -71.05% |